FindTrial
Sign In

To study the effect of bolus free dexmedetomidine infusion at minimal maintainence dose for hemodynamic stability & potentially blood less field intra operatively.

To study the effect of bolus-free dexmedetomidine infusion at minimal maintenance dose for hemodynamic stability and potentially blood less field intra operatively: A randomized, controlled, double-blinded, parallel-arm trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054851
Enrollment
60
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bolus free Dexmedetomidine infusion: Group B: will receive continuous infusion of dexmedetomidine at minimal rate of 0.2 mcg/kg/hr for maintenance of hemodynamic stability and potentia

Sponsors

Bharati Vidyapeeth Deemed University Medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18-65 years 2. Both genders 3. American Society of Anesthesiologists (ASA) Grading, I-II 4.Elective head, neck, face, middle ear, spine and neurosurgeries

Exclusion criteria

Exclusion criteria: 1. 65 years 2.Non-consenting as well as pregnant patients 3.Patients with uncontrolled co-existing systemic or metabolic diseases 4.History of alcohol or substance abuse or psychiatric illness 5.Known sensitivity to dexmedetomidine 6.BMI >30 kg/m2

Design outcomes

Primary

MeasureTime frame
To study & compare effects of intra operative dexmedetomidine with loading dose followed by continuous infusion & only continuous dexmedetomidine infusion at minimal prescribed rate for hemodynamic stability and potentially blood less field intraoperatively.Timepoint: one year—

Secondary

MeasureTime frame
To study & compare side effects/complications involved with dexmedetomidine with loading dose followed by continuous infusion and only continuous dexmedetomidine infusion without a loading dose.Timepoint: one year—

Countries

India

Contacts

Public ContactDr Neha Tilak

Bharati Vidyapeeth Deemed University Medical college and Hospital

tilakneha87@gmail.com9769622534

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026